We probably shouldn't gloss over the fact that this is their largest quarterly customer receipts...by a long way (at least based on the last two years):
The table above has some fairly simplistic assumptions. I've excluded all rebates and incentives from the CFO (Cash Flow from Operations) to get a more accurate view on PIQ's ability to generate cash. Adding back the R&D spend should hopefully get a view of the analytical business unit + any PromarkerD revenue. This is not perfect because it's reliant on cost allocation. However, it tells an important story about how significant this quarter just gone was...but to your point@Eqz, it would be great to know what the revenue split was...
- Forums
- ASX - By Stock
- PIQ
- Ann: Appendix 4C and Quarterly Report - March 2020
PIQ
proteomics international laboratories ltd
Add to My Watchlist
1.37%
!
37.0¢

Ann: Appendix 4C and Quarterly Report - March 2020, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
37.0¢ |
Change
0.005(1.37%) |
Mkt cap ! $60.56M |
Open | High | Low | Value | Volume |
36.5¢ | 37.0¢ | 35.0¢ | $51.50K | 144.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 18336 | 36.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.5¢ | 9405 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 18336 | 0.360 |
1 | 30000 | 0.355 |
3 | 31520 | 0.350 |
3 | 62919 | 0.340 |
1 | 2000 | 0.335 |
Price($) | Vol. | No. |
---|---|---|
0.390 | 11109 | 1 |
0.395 | 39195 | 2 |
0.400 | 14573 | 2 |
0.410 | 100000 | 1 |
0.420 | 10000 | 1 |
Last trade - 15.58pm 30/07/2025 (20 minute delay) ? |
Featured News
PIQ (ASX) Chart |